/PRNewswire/ Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune.
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 24,900 shares, a drop of 48.2% from the July 15th total of 48,100 shares. Approximately 0.3% of the company’s shares are short […]
/PRNewswire/ Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune.